Zura Bio Ltd ZURA
- torudokimab — Atopic Dermatitis Phase 2
IL-33 (2 companies · 2 programs)
Companies with an active program directed at IL-33.
Zymeworks Inc. ZYME
- ZW1528 — Chronic Obstructive Pulmonary Disease Preclinical
Companies with an active program directed at IL-33.